Aprea Therapeutics, Inc. (APRE)
0.695
-0.03
(-3.94%)
USD |
NASDAQ |
Oct 02, 16:00
0.6951
0.00 (0.00%)
After-Hours: 20:00
Aprea Therapeutics Price to Book Value : 0.2239 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 0.2239 |
| October 01, 2026 | 0.233 |
| September 30, 2026 | 0.2416 |
| September 29, 2026 | 0.2479 |
| September 28, 2026 | 0.2422 |
| September 25, 2026 | 0.2451 |
| September 24, 2026 | 0.2511 |
| September 23, 2026 | 0.2512 |
| September 22, 2026 | 0.2359 |
| September 21, 2026 | 0.2374 |
| September 18, 2026 | 0.2448 |
| September 17, 2026 | 0.2416 |
| September 16, 2026 | 0.2353 |
| September 15, 2026 | 0.2412 |
| September 14, 2026 | 0.2517 |
| September 11, 2026 | 0.2493 |
| September 10, 2026 | 0.2542 |
| September 09, 2026 | 0.2549 |
| September 08, 2026 | 0.2689 |
| September 04, 2026 | 0.2558 |
| September 03, 2026 | 0.2597 |
| September 02, 2026 | 0.2641 |
| September 01, 2026 | 0.2692 |
| August 31, 2026 | 0.2577 |
| August 28, 2026 | 0.2701 |
| Date | Value |
|---|---|
| August 27, 2026 | 0.277 |
| August 26, 2026 | 0.3157 |
| August 25, 2026 | 0.306 |
| August 24, 2026 | 0.2594 |
| August 21, 2026 | 0.2062 |
| August 20, 2026 | 0.2062 |
| August 19, 2026 | 0.2161 |
| August 18, 2026 | 0.2164 |
| August 17, 2026 | 0.2222 |
| August 14, 2026 | 0.219 |
| August 13, 2026 | 0.2161 |
| August 12, 2026 | 0.22 |
| August 11, 2026 | 0.2126 |
| August 10, 2026 | 0.2075 |
| August 07, 2026 | 0.2095 |
| August 06, 2026 | 0.2037 |
| August 05, 2026 | 0.20 |
| August 04, 2026 | 0.193 |
| August 03, 2026 | 0.1925 |
| July 31, 2026 | 0.1997 |
| July 30, 2026 | 0.2045 |
| July 29, 2026 | 0.20 |
| July 28, 2026 | 0.1977 |
| July 27, 2026 | 0.2012 |
| July 24, 2026 | 0.2036 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zymeworks, Inc. | 22.52 |
| Rhythm Pharmaceuticals, Inc. | 62.03 |
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
Price to Book Value Related Metrics
| PS Ratio | 2747.58 |
| Price | 0.695 |
| Earnings Yield | -154.9% |
| Market Cap | 8.612M |